Parasitic worms help Professor Clarissa Prazeres da Costa and her team better understand the human immune system in order to find solutions to global health problems.
Why do blood clots develop in the first place—and why do they tend to recur? LMU researcher Konstantin Stark believes that the answers lie in the immune system.
At RCI, the Regensburg Center for Interventional Immunology, international research groups develop immunotherapies and cellular therapies in order to help treating patients suffering from tumors, chronic inflammation or autoimmunity.
From junior research group leader to full professor and spokesperson of the Research Center for Infectious Diseases (ZINF) at the University of Würzburg. This is the scientific career path of Cynthia Sharma.
A research team at the University of Würzburg has, for the first time, uncovered how E. coli bacteria sneak into the prostate. The discovery reveals a hidden infection pathway and opens the door to potential new treatments for bacterial prostatitis.
Regulatory T cells (Tregs), a specialized type of immune cells, are usually seen as “peacekeepers” that prevent excessive immune attacks. Surprisingly, a new study published in “Signal Transduction and Targeted Therapy” shows that Tregs utilize inflammatory signals to start repair processes following cancer therapy. The research conducted by the LIT Cooperation Group “Innate Immune Sensing in Cancer and Transplantation” in cooperation with researchers from the Department of Radiation Oncology at the Technical University of Munich (TUM) uncovers how the body`s own immune system can be harnessed to repair the intestinal lining and improve survival.
Detect influenza viruses quickly and easily with chewing gum or a lollipop: researchers from Würzburg, Braunschweig and Cologne demonstrate with a new diagnostic tool how this works.
It is well established that gut microbiome composition plays a pivotal role in human health – yet the precise connections are still not fully elucidated. Researchers at the Technical University of Munich (TUM) have moved a step closer to understanding these complex interactions: they have identified a cellular mechanism that alters the gut microbiome in a way that promotes cancer. An analysis of patient data shows that the findings also apply to humans.
Six researchers from Würzburg have been awarded prestigious grants for their projects: the European Research Council's Starting Grants are worth €1.5 million each.
A study from Würzburg reveals: pox viruses have developed a unique strategy to rapidly multiply after infecting a host cell. The findings uncover a previously unknown role for a well-known molecule and may serve as a starting point for the development of new antiviral agents.
